AIRS, a South Korean company specializing in AI robotic solutions for fracture surgeries, has raised 5 billion KRW in Series A funding led by L&S Venture Capital to accelerate technology commercialization and global market expansion.

Target Company Overview

AIRS, an innovative company specializing in AI-driven robotic solutions for fracture surgeries, has secured a Series A investment of 5 billion KRW. The funding round was led by L&S Venture Capital, alongside participation from Reinvestment, O& Venture Investment, SL Investment, and the Korea Technology Finance Corporation. Established in 2020, AIRS seeks to digitize fracture surgery by applying advanced AI technology, thus enhancing the precision and reducing the risks associated with traditional surgical methods.

In conventional fracture operations, multiple orthopedic specialists interpret complex fracture conditions using 2D X-ray images, which can lead to errors and excessive radiation exposure. AIRS aims to resolve these issues with its advanced robotic systems, enhancing accuracy and patient safety during surgeries. The company's solutions comprise a surgical robot, navigation system, and fixation pins, allowing for precise bone alignment while minimizing radiation usage and enhancing the overall safety of the procedure.

Industry Overview in South Korea

The medical robotics industry in South Korea has seen unprecedented growth, propelled by advancements in AI, robotics, and minimally invasive surgical technologies. South Korea's government has actively supported this